病例报告：严重低磷血症的罕见病因。 - Suppr

Case report: A rare cause of severe hypophosphatemia.

作者信息

Román-Gimeno Sergio, Ortez-Toro José J, Peteiro-Miranda Carlos M, Sanz-Martín Borja, Urdaniz-Borque Rosana

机构信息

Department of Endocrinology and Nutrition, Hospital Clínico Universitario Lozano-Blesa, 15, San-Juan-Bosco avenue, 50009 Zaragoza, Spain.

出版信息

Ann Endocrinol (Paris). 2020 Jun;81(2-3):125-126. doi: 10.1016/j.ando.2020.04.008. Epub 2020 May 4.

DOI:10.1016/j.ando.2020.04.008

PMID:32409006

Abstract

摘要

相似文献

Case report: A rare cause of severe hypophosphatemia.病例报告：严重低磷血症的罕见病因。

Ann Endocrinol (Paris). 2020 Jun;81(2-3):125-126. doi: 10.1016/j.ando.2020.04.008. Epub 2020 May 4.

[Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron].[低磷血症，静脉使用铁剂鲜为人知的不良反应]

Med Clin (Barc). 2014 Sep 15;143(6):284-5. doi: 10.1016/j.medcli.2013.11.030. Epub 2014 Jan 22.

High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia.高剂量羧基麦芽糖铁用于射血分数降低的心力衰竭患者时会导致明显的低磷血症。

J Am Coll Cardiol. 2018 May 15;71(19):2270-2271. doi: 10.1016/j.jacc.2018.03.448.

Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient.一名营养不良患者静脉注射铁剂后出现严重且持久的低磷血症。

Eur J Clin Nutr. 2014 Apr;68(4):531-3. doi: 10.1038/ejcn.2014.20. Epub 2014 Feb 26.

Phosphorus levels in children treated with intravenous ferric carboxymaltose.接受静脉注射羧基麦芽糖铁治疗的儿童的磷水平

Am J Hematol. 2021 Jun 1;96(6):E215-E218. doi: 10.1002/ajh.26165. Epub 2021 Apr 7.

Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia.铁羧基麦芽糖治疗炎症性肠病儿童缺铁性贫血：疗效和低磷血症风险。

Dig Liver Dis. 2021 Jul;53(7):830-834. doi: 10.1016/j.dld.2021.02.017. Epub 2021 Mar 26.

[Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect].缺铁性贫血患者静脉注射羧麦芽糖铁相关的低磷血症。一种常见的副作用

Med Clin (Barc). 2015 Aug 7;145(3):108-11. doi: 10.1016/j.medcli.2014.10.016. Epub 2015 Jan 8.

Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration.因使用羧基麦芽糖铁导致的基于成纤维细胞生长因子23的严重低磷性骨软化症。

BMJ Case Rep. 2018 Jan 3;2018:bcr-2017-222851. doi: 10.1136/bcr-2017-222851.

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk.高剂量静脉铁剂的选择决定了低磷血症风险。

PLoS One. 2016 Dec 1;11(12):e0167146. doi: 10.1371/journal.pone.0167146. eCollection 2016.

Refractory hypophosphatemia following ferric carboxymaltose administration.静脉注射羧基麦芽糖铁后出现难治性低磷血症。

CEN Case Rep. 2021 Nov;10(4):473-475. doi: 10.1007/s13730-021-00590-1. Epub 2021 Mar 14.

引用本文的文献

Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports.羧基麦芽糖铁诱导严重不良事件的信号检测：FAERS和VigiBase数据的不成比例分析及病例报告的系统评价

Eur J Clin Pharmacol. 2025 May 22. doi: 10.1007/s00228-025-03849-z.

A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.对45项使用羧基麦芽糖铁的干预性试验中血清磷酸盐测量值和潜在低磷血症事件的汇总分析。

J Clin Med. 2020 Nov 6;9(11):3587. doi: 10.3390/jcm9113587.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Case report: A rare cause of severe hypophosphatemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献